House pan­el ad­vances bills tar­get­ing rare dis­ease, pri­or­i­ty re­view vouch­ers

WASH­ING­TON — Law­mak­ers ad­vanced the reau­tho­riza­tion of an FDA pro­gram de­signed to stim­u­late the de­vel­op­ment of treat­ments for pe­di­atric rare dis­eases, de­spite some op­po­si­tion from De­mo­c­rat …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER